1 in 6 Gen Z South Koreans took GLP-1 slimming drugs last year
A new survey shows appearance drives slimming drug use among young South Koreans, while regulators battle scams and misinformation
The 2026 Korea Wellness Report, released by KB Financial Group on Sunday and cited by The Korea Times, surveyed 2,000 men and women aged 25 to 69 between July and August. Across all age brackets, the overall uptake stood at 10.3 per cent.
Gen Z adults – defined in the study as those born after 1995 – recorded the highest uptake at 16.5 per cent, followed by millennials at 14.2 per cent, Gen X at 7.7 per cent and baby boomers at 2.9 per cent.
